Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2011-01-14
Original SEC Filing: Click here

---

Webplus: TPI/20110114/8-K/2_EX-99.1/000.htm SEC Original: ex99one.htm
R E C I T A L S NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows: 1. Amendment Issuance of Additional Shares of Common Stock “ 2. Effective Time 3. Effect on Transaction Documents 4. Governing Law; Jurisdiction 5. Counterparts 6. Severability [REMAINDER OF THIS

---

---

Webplus: TPI/20110114/8-K/1/000.htm SEC Original: tpi8k11411.htm
CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT January 14, 2010 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co., Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 8 –

---

Company Information:

Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2011-01-14CIK: 0001362718, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
23RD FLOOR, UNIONSUN YANGKUO PLAZA
CHENGDU, P.R. 610041